Rivastigmine (Sandoz Inc)
Welcome to the PulseAid listing for the Rivastigmine drug offered from Sandoz Inc. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | rivastigmine |
| SUBSTANCE NAME: | RIVASTIGMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2015-09-02 |
| END MARKETING DATE: | 0000-00-00 |
Rivastigmine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rivastigmine from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4.6(mg/24h) |
| START MARKETING DATE: | 2015-09-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0781-7304_92a58ebb-748d-49f4-bf11-ecbcf5424152 |
| PRODUCT NDC: | 0781-7304 |
| APPLICATION NUMBER: | NDA022083 |
Other RIVASTIGMINE Pharmaceutical Manufacturers / Labelers:
